​

At this time, the Australian Psychological Society (APS) has not yet officially endorsed Neurofeedback as a recommended treatment option for the conditions listed on our site. Even with a strong evidence-base, NFB is still not fully adopted as a first-line or adjunct treatment for conditions like ADHD and anxiety. Meanwhile, the behavioral health arena remains desperate for effective treatment options as rates of disorders continue to rise. As such, The Brain Training Centre offers the following recommendations:

 

Consumers and Patients Make Their Interest in NFB Clear to Providers. With growing awareness of neuroplasticity and brain health and fitness, consumers and patients can advocate for medical and psychological practitioners to make NFB part of a broader standard toolkit to address mental health, brain fitness, and well-being. By directing providers to this brief and other NFB resources, including the websites of state, regional, and (inter)national professional associations for NFB and biofeedback, the public can greatly influence the attention providers pay to this intervention.  

​

The fastest path to clinical and responsible access is for medicare providers and private health funds to acknowledge NFB as a first-line or adjunct treatment for patients with ADHD or stress- and adjustment-related symptoms, and to take action for this change to happen. Increasing coverage of NFB as a treatment for behavioural health would also help in the battle to reduce rates of behavioural health conditions across the population. 

​

With advances in technology and technique in the field of NFB, and more rigorous certification available to ensure treatment standards, there has never been a better time to increase adoption of NFB into the mental and behavioural health treatment paradigms for a broad range of conditions, and as a treatment option for improving brain health and well-being.